Context Therapeutics Inc. (CNTX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -11.43M | -8.94M | -6.58M | -5.84M | -5.03M | -4.91M | -1.93M | -3.36M | -4.36M | -7.23M | -3.46M | -4.63M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -127.3% | -82.25% | -240.29% | -73.89% | -15.31% | 32.1% | 44.14% | 27.54% | 23.88% | -83.91% | -15.59% | -65.09% |
| Net Income | -8.68M | -13.03M | -9.69M | -8.83M | -4.58M | -3.34M | -17.46M | -2.25M | -3.67M | -6.77M | -5.87M | -5.01M |
| Depreciation & Amortization | 36.1K | 4.07K | 4.07K | 4.07K | 4.05K | 2.93K | 2.81K | 2.57K | 2.57K | 2.57K | 3.09K | 3.19K |
| Stock-Based Compensation | 0 | 325.17K | 323.08K | 389.11K | 293.72K | 231.82K | 213K | 157.04K | 240.01K | 256.05K | 254.95K | 283.1K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 294.02K | 0 | 0 |
| Other Non-Cash Items | 409.22K | 2.03M | 27.46K | 26.73K | 26.01K | 25.32K | 15.23M | 0 | 0 | -294.02K | 7.52K | 22.37K |
| Working Capital Changes | -3.19M | 1.73M | 2.76M | 2.57M | -774.9K | -1.82M | 82.46K | -1.26M | -935.4K | -715.9K | 2.15M | 71.55K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -67.16K | -187.99K | 325K | 1.39M | -435.64K | 408.25K | 0 | -1.48M | -337.65K | 555.21K | 636.95K | -19.41K |
| Cash from Investing | -37.26K | -2M | 0 | 0 | -33.95K | 0 | -14.76M | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | -37.26K | -2M | 0 | 0 | -33.95K | 0 | -7.32K | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | -14.75M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 0 | 0 | 0 | -15.27K | 14.54M | -44.63K | 94.8M | 0 | 0 | 0 | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 14.54M | -44.63K | 94.8M | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -44.63K | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | -15.27K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -11.47M | -10.94M | -6.58M | -5.84M | -5.08M | 9.63M | -16.73M | 91.45M | -4.36M | -7.23M | -3.46M | -4.63M |
| Free Cash Flow | -11.47M | -8.94M | -6.58M | -5.84M | -5.06M | -4.91M | -1.94M | -3.36M | -4.36M | -7.23M | -3.46M | -4.63M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -126.51% | -82.25% | -239% | -73.89% | -16.09% | 32.1% | 43.93% | 27.54% | 23.88% | -83.91% | 0.95% | -64.98% |
| FCF per Share | -0.12 | -0.10 | -0.07 | -0.06 | -0.05 | -0.08 | -0.02 | -0.06 | -0.27 | -0.45 | -0.22 | -0.29 |
| FCF Conversion (FCF/Net Income) | 1.32x | 0.69x | 0.68x | 0.66x | 1.10x | 1.47x | 0.11x | 1.49x | 1.19x | 1.07x | 0.59x | 0.92x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |